ADDISON HOUSE - HAQUE PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: F81181 | HARLOW, CM20 1DS
Showing results 301-350 of 738
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Estradiol | 137 | 3,256 | £1.8K | -49.2% ▼ |
| Pizotifen malate | 136 | 3,262 | £154 | +65.0% ▲ |
| Guanfacine | 134 | 5,086 | £10.0K | +421.5% ▲ |
| Isophane insulin | 134 | 813 | £3.7K | +26.9% ▲ |
| Metoclopramide hydrochloride | 133 | 4,695 | £174 | +60.5% ▲ |
| Bempedoic acid/Ezetimibe | 132 | 3,304 | £6.2K | +116.2% ▲ |
| Adrenaline | 132 | 251 | £14.9K | +109.3% ▲ |
| Benzydamine hydrochloride | 132 | 10.4K | £571 | +70.7% ▲ |
| Dutasteride | 129 | 3,535 | £204 | +151.2% ▲ |
| Alfuzosin hydrochloride | 128 | 3,672 | £1.5K | +78.9% ▲ |
| Neomycin sulfate | 128 | 1,935 | £245 | +115.9% ▲ |
| Benzoyl peroxide | 128 | 11.3K | £1.1K | +808.3% ▲ |
| Ispaghula husk | 127 | 5,350 | £1.1K | -3.6% ▼ |
| Cinnarizine | 126 | 8,890 | £408 | +169.3% ▲ |
| Amiodarone hydrochloride | 125 | 2,121 | £124 | +93.8% ▲ |
| Etoricoxib | 124 | 3,941 | £973 | +53.9% ▲ |
| Leflunomide | 123 | 3,690 | £211 | +225.0% ▲ |
| Benzoyl peroxide and clindamycin phosphate | 123 | 4,470 | £1.9K | +83.5% ▲ |
| 122 | 3,513 | £3.2K | +228.7% ▲ | |
| Risedronate sodium | 116 | 880 | £419 | -4.4% ▼ |
| Flecainide acetate | 114 | 6,692 | £256 | +46.0% ▲ |
| Olopatadine | 114 | 600 | £560 | +159.9% ▲ |
| Ipratropium bromide | 113 | 3,347 | £1.1K | +293.1% ▲ |
| Hydroxyzine hydrochloride | 110 | 4,610 | £1.4K | +106.5% ▲ |
| Norethisterone | 109 | 5,248 | £829 | +124.7% ▲ |
| Desloratadine | 108 | 3,774 | £374 | +274.4% ▲ |
| Cyclizine lactate | 108 | 1,505 | £1.4K | +620.0% ▲ |
| Typhoid | 108 | 108 | £1.1K | +19.9% ▲ |
| Anastrozole | 107 | 2,408 | £93 | +17.5% ▲ |
| Oral rehydration salts | 106 | 1,173 | £534 | +266.9% ▲ |
| 106 | 1,186 | £3.2K | +141.1% ▲ | |
| 106 | 3,750 | £200 | +95.3% ▲ | |
| 105 | 1,347 | £2.7K | +277.4% ▲ | |
| Midazolam hydrochloride | 104 | 1,103 | £610 | +154.1% ▲ |
| Water for injection | 103 | 1,100 | £349 | +204.5% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 102 | 17.3K | £1.3K | -32.5% ▼ |
| Insulin degludec | 101 | 763 | £7.1K | -8.1% ▼ |
| Sodium chloride | 101 | 3,731 | £2.3K | +239.6% ▲ |
| Moxonidine | 99 | 1,715 | £250 | +77.8% ▲ |
| 99 | 1,685 | £2.0K | +151.2% ▲ | |
| 99 | 5,563 | £283 | +98.4% ▲ | |
| 98 | 5,600 | £391 | +40.4% ▲ | |
| Powder extensively hydrolysed formula (0913101) | 97 | 203.2K | £5.9K | +34.6% ▲ |
| 97 | 535 | £595 | +211.5% ▲ | |
| 97 | 1,070 | £3.3K | +376.4% ▲ | |
| Midodrine hydrochloride | 96 | 5,782 | £1.1K | +97.0% ▲ |
| Erythromycin ethylsuccinate | 96 | 12.5K | £1.2K | +311.2% ▲ |
| Mycophenolate mofetil | 96 | 7,937 | £3.9K | +137.1% ▲ |
| 96 | 1,475 | £2.5K | +277.9% ▲ | |
| Pimecrolimus | 95 | 3,400 | £2.1K | +461.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.